Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-25-002859
Filing Date
2025-01-17
Accepted
2025-01-17 19:47:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 17241
2 ex1.htm EX-1 7919
3 ex2.htm EX-2 22299
  Complete submission text file 0001493152-25-002859.txt   49022
Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Subject) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-94604 | Film No.: 25540100
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 ATLANTIC AVENUE SUITE M2 LYNBROOK NY 11563
Business Address
Auerbach Shalom (Filed by) CIK: 0002048828 (see all company filings)

Type: SCHEDULE 13D